Diclofenac-Darnitsa
Release form:
Release form:
– Inflammatory and degenerative forms of rheumatic diseases (rheumatoid arthritis, ankylosing spondylitis, osteoarthrosis, spondylarthritis) – Spinal pain syndrome – Soft tissue rheumatism – Acute gout attacks – Posttraumatic and postoperative pain accompanied by inflammation and edema, for example, after dental and orthopedic procedures – Gynecological diseases accompanied by pain and inflammation, for example, primary dysmenorrhea or adnexitis – As an adjuvant, it can be used in severe inflammatory ENT diseases accompanied by pain, for example, in pharyngotonsillitis, otitis. According to the general therapeutical principles, the primary disease should be treated with basic drug therapy agents. Fever by itself is not considered an indication for use of the drug